Real-time enrollment status for this ocular myasthenia gravis clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:43 PM UTC
| NCT Number | NCT07465289 |
| Recruiting Status | Recruiting |
| Condition | Ocular Myasthenia Gravis |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | October 8, 2026 (1 week ago) |
As of October 15, 2026: Clinical trial NCT07465289 is currently recruiting participants. This phase3 study for ocular myasthenia gravis is actively seeking new participants at 1 location across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07465289 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07465289 was last updated 1 week ago (October 8, 2026). HelloStudys verifies this status automatically.